Amphastar Pharmaceuticals (AMPH) News Today → 41 banks launch ‘crypto dollar’ (From Stansberry Research) (Ad) Free AMPH Stock Alerts $43.14 -0.34 (-0.78%) (As of 03:52 PM ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 20 at 5:29 AM | seekingalpha.comAmphastar Pharmaceuticals: Profitable Pharma With Strong GrowthMay 20 at 5:27 AM | marketbeat.comBNP Paribas Financial Markets Cuts Holdings in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH)BNP Paribas Financial Markets lowered its holdings in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH - Free Report) by 20.1% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 97,806 shares of the company's stock after seMay 16, 2024 | investorplace.comPatent Peril: 3 Stocks at Risk From the FTC's Drug CrusadeMay 15, 2024 | seekingalpha.comReassessing Amphastar PharmaceuticalsMay 15, 2024 | finance.yahoo.comImplied Volatility Surging for Amphastar (AMPH) Stock OptionsMay 15, 2024 | americanbankingnews.comStockNews.com Upgrades Amphastar Pharmaceuticals (NASDAQ:AMPH) to "Buy"May 13, 2024 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: Teva Pharmaceutical (TEVA), Globus Medical (GMED) and DENTSPLY SIRONA (XRAY)May 12, 2024 | americanbankingnews.comAmphastar Pharmaceuticals (NASDAQ:AMPH) Earns "Hold" Rating from Needham & Company LLCMay 12, 2024 | marketbeat.comAmphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Shares Sold by Russell Investments Group Ltd.Russell Investments Group Ltd. reduced its stake in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH - Free Report) by 51.2% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 63,667 shares of the company's stock aMay 11, 2024 | marketbeat.comMesirow Institutional Investment Management Inc. Raises Holdings in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH)Mesirow Institutional Investment Management Inc. raised its position in shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH - Free Report) by 37.6% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 252,8May 10, 2024 | finance.yahoo.comAmphastar Pharmaceuticals Reports Strong First Quarter Earnings, Surpassing Analyst Revenue ...May 10, 2024 | finance.yahoo.comAmphastar Pharmaceuticals First Quarter 2024 Earnings: EPS: US$0.90 (vs US$0.54 in 1Q 2023)May 9, 2024 | finanznachrichten.deAmphastar Pharmaceuticals, Inc.: Amphastar Pharmaceuticals to Present at the Bank of America Securities Health Care ConferenceMay 9, 2024 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: Amphastar Pharmaceuticals (AMPH) and Erasca (ERAS)May 9, 2024 | markets.businessinsider.comAmphastar Pharmaceuticals: Hold Rating Justified Amidst Growth Prospects and Pipeline PotentialMay 9, 2024 | insidermonkey.comAmphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Q1 2024 Earnings Call TranscriptMay 9, 2024 | marketbeat.comAmphastar Pharmaceuticals (NASDAQ:AMPH) Shares Gap Up to $42.21Amphastar Pharmaceuticals (NASDAQ:AMPH) Shares Gap Up to $42.21May 9, 2024 | finance.yahoo.comAmphastar Pharmaceuticals Inc (AMPH) Q1 2024 Earnings Call Transcript Highlights: Robust Growth ...May 9, 2024 | finance.yahoo.comQ1 2024 Amphastar Pharmaceuticals Inc Earnings CallMay 9, 2024 | marketbeat.comAmphastar Pharmaceuticals (NASDAQ:AMPH) Receives Hold Rating from Needham & Company LLCNeedham & Company LLC restated a "hold" rating on shares of Amphastar Pharmaceuticals in a report on Thursday.May 8, 2024 | investorplace.comAMPH Stock Earnings: Amphastar Pharma Beats EPS, Misses Revenue for Q1 2024May 8, 2024 | washingtonpost.comAmphastar: Q1 Earnings SnapshotMay 7, 2024 | markets.businessinsider.comWhat Wall Street expects from Amphastar Pharmaceuticals's earningsMay 7, 2024 | marketbeat.comLSV Asset Management Has $19.64 Million Position in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH)LSV Asset Management boosted its holdings in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH - Free Report) by 49.6% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 317,600 shares of the company's stock aftMay 3, 2024 | insidertrades.comAmphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Director Floyd F. Petersen Sells 500 SharesMay 1, 2024 | marketbeat.comAmphastar Pharmaceuticals (AMPH) Scheduled to Post Quarterly Earnings on WednesdayAmphastar Pharmaceuticals (NASDAQ:AMPH) will be releasing earnings after the market closes on Wednesday, May 8, Zacks reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=418090)May 1, 2024 | marketbeat.comAmphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Sees Large Increase in Short InterestAmphastar Pharmaceuticals, Inc. (NASDAQ:AMPH - Get Free Report) saw a significant growth in short interest during the month of April. As of April 15th, there was short interest totalling 3,870,000 shares, a growth of 5.4% from the March 31st total of 3,670,000 shares. Based on an average daily volume of 430,500 shares, the short-interest ratio is currently 9.0 days. Approximately 11.0% of the company's stock are sold short.April 30, 2024 | finance.yahoo.comAmphastar Pharmaceuticals to Release First Quarter Earnings and Hold Conference Call on May 8, 2024April 30, 2024 | msn.comFTC Targets ‘Junk’ Patent Listings on Ozempic and Other DrugsApril 24, 2024 | marketbeat.comLouisiana State Employees Retirement System Takes $1.16 Million Position in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH)Louisiana State Employees Retirement System bought a new position in shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH - Free Report) in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor bought 18,700 shareApril 22, 2024 | marketbeat.comCalamos Advisors LLC Takes Position in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH)Calamos Advisors LLC purchased a new position in shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH - Free Report) during the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor purchased 19,479 shares of the company's stock, valued at approximatelyApril 19, 2024 | marketbeat.comAmphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Forecasted to Post FY2024 Earnings of $3.48 Per ShareAmphastar Pharmaceuticals, Inc. (NASDAQ:AMPH - Free Report) - Stock analysts at Capital One Financial raised their FY2024 earnings per share estimates for Amphastar Pharmaceuticals in a report released on Wednesday, April 17th. Capital One Financial analyst T. Chiang now forecasts that the companApril 18, 2024 | marketbeat.comFederated Hermes Inc. Has $202.42 Million Stake in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH)Federated Hermes Inc. decreased its holdings in shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH - Free Report) by 4.9% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 3,272,761 shares of the company's stock after sellingApril 18, 2024 | marketbeat.comEquities Analysts Offer Predictions for Amphastar Pharmaceuticals, Inc.'s Q1 2024 Earnings (NASDAQ:AMPH)Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH - Free Report) - Equities researchers at Capital One Financial issued their Q1 2024 earnings per share estimates for shares of Amphastar Pharmaceuticals in a research report issued on Wednesday, April 17th. Capital One Financial analyst T. Chiang forecApril 18, 2024 | markets.businessinsider.comAmphastar Pharmaceuticals Poised for Growth: Strong Generic Pipeline and Strategic Marketing Drive Buy RatingApril 16, 2024 | finance.yahoo.comNaloxone Market To Reach USD 2,478.6 Million By 2032 | DataHorizzon ResearchApril 15, 2024 | marketbeat.comAmphastar Pharmaceuticals (NASDAQ:AMPH) Stock Price Up 3%Amphastar Pharmaceuticals (NASDAQ:AMPH) Trading Up 3%April 12, 2024 | marketbeat.comShaker Investments LLC OH Increases Stock Position in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH)Shaker Investments LLC OH boosted its stake in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH - Free Report) by 136.0% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 49,078 shares of the company's stock aApril 12, 2024 | finance.yahoo.comAmphastar Pharmaceuticals (NASDAQ:AMPH) shareholders YoY returns are lagging the company's 66% three-year earnings growthApril 10, 2024 | marketbeat.comAmphastar Pharmaceuticals' (AMPH) Hold Rating Reaffirmed at Needham & Company LLCNeedham & Company LLC reaffirmed a "hold" rating on shares of Amphastar Pharmaceuticals in a report on Wednesday.April 10, 2024 | marketbeat.comRaymond James & Associates Acquires 39,916 Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH)Raymond James & Associates lifted its holdings in shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH - Free Report) by 75.7% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 92,659 shares of the company'sApril 9, 2024 | msn.comAmphastar Pharmaceuticals (NASDAQ:AMPH) Offers Savvy Value Investors a Window of OpportunityApril 9, 2024 | marketbeat.comMoody Aldrich Partners LLC Invests $3.90 Million in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH)Moody Aldrich Partners LLC purchased a new stake in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH - Free Report) in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund purchased 63,114 shares of the company's stock, valued at approximately $3,904,000. MoodyApril 5, 2024 | marketbeat.comSG Americas Securities LLC Sells 42,008 Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH)SG Americas Securities LLC cut its holdings in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH - Free Report) by 82.8% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 8,719 shares of the company's stock after selling 42,008 shares during the period.April 4, 2024 | msn.comAmphastar Pharmaceuticals (AMPH) Stock Moves -1%: What You Should KnowApril 4, 2024 | insidertrades.comInsider Selling: Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Director Sells 500 Shares of StockApril 3, 2024 | marketbeat.comAmphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Director Sells $21,715.00 in StockAmphastar Pharmaceuticals, Inc. (NASDAQ:AMPH - Get Free Report) Director Floyd F. Petersen sold 500 shares of the business's stock in a transaction on Monday, April 1st. The shares were sold at an average price of $43.43, for a total value of $21,715.00. Following the completion of the transaction, the director now owns 79,333 shares of the company's stock, valued at $3,445,432.19. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink.March 25, 2024 | marketbeat.comAmphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Shares Purchased by American Century Companies Inc.American Century Companies Inc. lifted its stake in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH - Free Report) by 52.2% in the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 200,277 shares of the company's stock after purchasing an additionalMarch 18, 2024 | markets.businessinsider.comAnalysts’ Top Healthcare Picks: Soleno Therapeutics (SLNO), Optinose (OPTN)March 18, 2024 | marketbeat.comWalleye Capital LLC Invests $1.83 Million in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH)Walleye Capital LLC purchased a new position in shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH - Free Report) during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 39,854 shares of the company's stock, valued at Get Amphastar Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for AMPH and its competitors with MarketBeat's FREE daily newsletter. Email Address Warren Buffett's "mystery stock" (Ad)WARNING: Read This Before the Next Fed Meeting Investors are looking to the Fed with high hopes for interest rate relief. Unfortunately, many have no idea there's another major story unfolding right now, one that could be worth $40 trillion. This Wall Street millionaire just stepped forward with all the details, and how it could make some AMPH Media Mentions By Week AMPH Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. AMPH News Sentiment▼0.420.42▲Average Medical News Sentiment AMPH News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. AMPH Articles This Week▼74▲AMPH Articles Average Week Get Amphastar Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for AMPH and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: DCPH News Today AMRX News Today KROS News Today RCKT News Today EWTX News Today SNDX News Today NAMS News Today ARDX News Today GLPG News Today AGIO News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:AMPH) was last updated on 5/20/2024 by MarketBeat.com Staff From Our PartnersThe ONE AI Stock to own now. (It’s not Nvidia.)Weiss RatingsThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldDems have chosen Biden replacement?Paradigm PressDoes this make you sick?Allegiance GoldThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaThis Apple-like Innovator is Revolutionizing HealthcareWall Street Star**Breaking News** LIttle Known Biotech Company Does $41 Million In Q1! Huge AlertsWarren Buffett's "mystery stock"Stansberry Research Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Amphastar Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
